BAMCO Inc’s Encompass Health EHC Stock Holding History

BAMCO Inc’s Portfolio EHC Stock Details EHC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-17,500	Closed	-$1.86M	–	336
2025 Q4	$1.86M	Hold	17,500	–	–	0.01%	283
2025 Q3	$2.22M	Hold	17,500	–	–	0.01%	275
2025 Q2	$2.15M	Buy	+17,500	New	+$2M	0.01%	271

Other funds holding EHC

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return

Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return

BAMCO Inc's EHC Position: Q1 2026 in Review

BAMCO Inc sold out of Encompass Health (EHC) in Q1 2026, closing a stake of 17,500 shares — an estimated $1.86M sold.

BAMCO Inc first reported a position in EHC in Q2 2025 and held it in 3 quarters. The position peaked at $2.22M in Q3 2025. 580 funds tracked by Wall St. Rank hold EHC as of Q1 2026.

BAMCO Inc reported no remaining Encompass Health position as of Q1 2026 after selling out during the quarter.
BAMCO Inc sold 17,500 Encompass Health shares in Q1 2026, an estimated $1.86M.
BAMCO Inc first reported a position in Encompass Health in Q2 2025 and held it in 3 quarters.
BAMCO Inc's Encompass Health position peaked at $2.22M in Q3 2025.
580 funds tracked by Wall St. Rank held Encompass Health as of Q1 2026.

Based on BAMCO Inc's 13F filing for Q1 2026, filed 15 May 2026.